Lanean...

Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids

The novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans. Here, we will provide an overview of therapeutic options for COVID-19. Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with se...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int Immunopharmacol
Egile Nagusiak: Saghazadeh, Amene, Rezaei, Nima
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier B.V. 2020
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7205724/
https://ncbi.nlm.nih.gov/pubmed/32413736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106560
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!